Jeff Garro
Stock Analyst at Stephens & Co.
(0.74)
# 4,062
Out of 5,132 analysts
57
Total ratings
28.21%
Success rate
-13.88%
Average return
Main Sectors:
Stocks Rated by Jeff Garro
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CERT Certara | Maintains: Overweight | $15 → $12 | $6.67 | +79.91% | 6 | Dec 12, 2025 | |
| PRVA Privia Health Group | Reiterates: Overweight | $32 | $21.50 | +48.84% | 6 | Dec 4, 2025 | |
| OPRX OptimizeRx | Maintains: Equal-Weight | $20 → $17 | $8.21 | +107.06% | 4 | Nov 17, 2025 | |
| EVH Evolent Health | Reiterates: Equal-Weight | $9 | $2.64 | +240.91% | 6 | Sep 24, 2025 | |
| PHR Phreesia | Reiterates: Overweight | $32 | $11.86 | +169.81% | 9 | Sep 3, 2025 | |
| SLP Simulations Plus | Maintains: Overweight | $28 → $20 | $12.11 | +65.15% | 2 | Jul 15, 2025 | |
| TBRG TruBridge | Reiterates: Equal-Weight | $28 | $18.85 | +48.54% | 3 | Apr 10, 2025 | |
| VEEV Veeva Systems | Reiterates: Overweight | $280 | $171.99 | +62.80% | 2 | Mar 6, 2025 | |
| HCAT Health Catalyst | Maintains: Equal-Weight | $7 → $5 | $1.84 | +171.74% | 4 | Mar 6, 2025 | |
| DH Definitive Healthcare | Initiates: Equal-Weight | $5 | $1.54 | +225.73% | 1 | Dec 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $55 | $24.71 | +122.58% | 1 | Dec 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $250 | $168.85 | +48.06% | 2 | Dec 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $17 | $19.36 | -12.19% | 1 | Dec 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Equal-Weight | $28 | $4.47 | +526.40% | 2 | Jul 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 → $20 | $20.05 | -0.25% | 3 | Aug 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $5 → $3.9 | $8.35 | -53.29% | 2 | May 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $4 → $3 | $0.84 | +256.00% | 3 | May 6, 2022 |
Certara
Dec 12, 2025
Maintains: Overweight
Price Target: $15 → $12
Current: $6.67
Upside: +79.91%
Privia Health Group
Dec 4, 2025
Reiterates: Overweight
Price Target: $32
Current: $21.50
Upside: +48.84%
OptimizeRx
Nov 17, 2025
Maintains: Equal-Weight
Price Target: $20 → $17
Current: $8.21
Upside: +107.06%
Evolent Health
Sep 24, 2025
Reiterates: Equal-Weight
Price Target: $9
Current: $2.64
Upside: +240.91%
Phreesia
Sep 3, 2025
Reiterates: Overweight
Price Target: $32
Current: $11.86
Upside: +169.81%
Simulations Plus
Jul 15, 2025
Maintains: Overweight
Price Target: $28 → $20
Current: $12.11
Upside: +65.15%
TruBridge
Apr 10, 2025
Reiterates: Equal-Weight
Price Target: $28
Current: $18.85
Upside: +48.54%
Veeva Systems
Mar 6, 2025
Reiterates: Overweight
Price Target: $280
Current: $171.99
Upside: +62.80%
Health Catalyst
Mar 6, 2025
Maintains: Equal-Weight
Price Target: $7 → $5
Current: $1.84
Upside: +171.74%
Definitive Healthcare
Dec 20, 2024
Initiates: Equal-Weight
Price Target: $5
Current: $1.54
Upside: +225.73%
Dec 20, 2024
Initiates: Equal-Weight
Price Target: $55
Current: $24.71
Upside: +122.58%
Dec 20, 2024
Initiates: Overweight
Price Target: $250
Current: $168.85
Upside: +48.06%
Dec 9, 2024
Initiates: Buy
Price Target: $17
Current: $19.36
Upside: -12.19%
Jul 26, 2023
Reiterates: Equal-Weight
Price Target: $28
Current: $4.47
Upside: +526.40%
Aug 5, 2022
Maintains: Overweight
Price Target: $15 → $20
Current: $20.05
Upside: -0.25%
May 11, 2022
Maintains: Underweight
Price Target: $5 → $3.9
Current: $8.35
Upside: -53.29%
May 6, 2022
Maintains: Neutral
Price Target: $4 → $3
Current: $0.84
Upside: +256.00%